FGP
AHCO icon

Freestone Grove Partners’s AdaptHealth AHCO Stock Holding History

Freestone Grove Partners’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Buy
+18,844
New +$210K ﹤0.01% 795

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Freestone Grove Partners's AHCO Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in AdaptHealth (AHCO) in Q2 2026: 18,844 shares worth $196K. The stake represents ﹤0.01% of the portfolio and ranks #795 among its holdings.

238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Freestone Grove Partners held 18,844 shares of AdaptHealth worth $196K as of Q2 2026.
  • AdaptHealth was a new Freestone Grove Partners position in Q2 2026.
  • AdaptHealth made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #795 holding.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.